Final Program [International Conference on AIDS (14th: 2002: Barcelona, Spain)]

Oral Sessions 16:oo - 17:10

Wednesdav lulv 1io,%.F a %A IL ftor %* ft.0 %0 a v6ff 3 3 fto d6 IF a 1W.F %P ON/ v A.. - 7 --

E09 INeedles Are Not Just for Threading: New Drug Scenes
Oral Abstract Session
Venue: Hall 2:5
Date: Wednesday, July o10, 2002
Time: 16:oo-17:30
Chairs: Samuel Friedman, United States
Maria jose Bravo, Spain

17:00oo WeOrFl366
17:15 WeOrFl367

Disclosure of HIV serostatus to partners
among patients taking antiretroviral
treatment (ARV): experience from
Abidjan, Cote d'Ivoire
M Kabore, R Konan-Koko, S Eholie,
E Bissagnene, R Aka Kacou, A Kadio
(Cote d'lvoire)
Assessing and improving adherence to
highly active anti-retroviral therapy
among socially disadvantaged persons
living with HIV/AIDS in Rio de Janeiro,
Brazil
C Carneiro-da-Cunha, D Kerrigan,
M Malta', M Fortuna', S Strathdee2,
F Bastos' ('Brazil; 2United States)

16:oo WeOrE1356
16:15 WeOrE1357
16:3o WeOrE1358
16:45 WeOrE1359
17:00oo WeOrE136o
17:15 WeOrE1361

The effect of race, neighborhood, and
social network on adolescent initiation of
injection drug use among recent-onset
injection drug users in Baltimore,
Maryland
CM Fuller L N Borrell, S Galea, D Vlahov
(United States)
Capturing the illusion of injecting drug
use cultures: an ethnographic approach
S Slavin (Australia)
Community acceptance of controversial
HIV prevention programs for IDUs
D C Des Jarlais, M Downing, K Vernon,
T H Riess, N Mulia, C McKnight, B R Edlin
(United States)
HIV knowledge and risk behaviors
among Pakistani and Afghan heroin
users in Quetta, Pakistan
S TZa ar', H Brahmbhatt2,
S ul Hassan', S A Strathdee2
('Pakistan; 2United States)
Injected cocaine, free base and glue;
harm reduction programmes among
marginal Argentinian population
S Inchaurraqa, G Hurtado, M Escudero,
N Trincheri, M Rossi, M Rossi, S Quevedo
(Argentina)
A qualitative study on HIV risk among
injecting drug users in Vietnam: reasons
for sharing syringes and needles
V Dao Quang Vinh (Vietnam)

[ G09 Data for Policy
4 Oral Abstract Session
Venue: Hall 2:2
Date: Wednesday, July 10, 2002
Time: 16:oo00 - 17:30
Chairs: Ties Boerma, United States
Jorge Saavedra; Mexico TBC

16:oo WeOrG1368

Non-sustained financing of HIV
prevention interventions: what do we
lose?
L Kumaranayake, C Watts, P Vickerman
(United Kingdom)

Wednesday FIO Prevention - Treatment Continuum
0 Oral Abstract Session
Venue: Hall 5:7
Date: Wednesday, July 10, 2002
Time: 16:oo - 17:3o0
Chairs: Mary O'Grady, United States
Cesar Castellano, Dominican Republic
16:oo WeOrFl362 Strengthening HIV/AIDS care and
support also improves prevention
services
C1 Castle', S Solomon,
S Swarnalakshmi2, S Thomas2, S Priya2,
C Costello-Daly2o ('United States; 2/ndia)

16:15 WeOrGl369 Aligning the U.S. HIV prevention budget
with national goals to reduce new
infections by half
R 0 Valdiserri L Ogden, R Janssen,
/ Onorato (United States)
16:3o WeOrG137o Making a case: using international data
to lobby for effective HIV prevention in
low prevalence countries
M Rahman', TAzim', P Baatsen',
E Pisani2 ('Bangladesh; 2/ndonesia)
16:45 WeOrGl371 Cost measurement of HIV/AIDS
prevention and treatment in African
countries: lessons for obtaining reliable
estimates under international
collaboration
A P Beaston-Blaakman',
M Tselayakgosi2, R Saint-Victor2,
N Traord3, I Semini4 ('United States;
2Botswana; 3Mali; 4Switzerland)
17:00 WeOrGl372 How much will antiretroviral treatment
programs really cost? A policy tool for
estimating annual costs of providing
treatment in the public sector in a low
resource country
DayA K Nandakumar, C Connor,
G Kombe, A Frakt, M Murphy, C Leighton
(United States)

16:15 WeOrFl363
16:30 WeOrFl364
16:45 WeOrFl365

Strengthening non-medical caregivers to
enhance early diagnosis and treatment
of HIV/AIDS opportunistic infections
TK Kantayaporn, SK Kitsuwanarat,
P H Harinwan, S B Baker, P R Rumakom
(Thailand)
HIV positive youth on HAART are less
risky, not more
MA Etzel, WS Comulada,
D T Swendeman, M J Rotheram-Borus,
KM Mattes, R E Weiss (United States)
Improvement of adherence in severe
non-adherent patients after the
intervention of a treatment adherence
counsellor
A Carmona (Spain)

17:15 WeOrGl373

Behavioural surveillance surveys in the
Africa region: how well do we
understand the epidemic?
C Pervilhac J Calleja, N Walker, P Ghys
(WHO)

146 Final Program